Need a Consultant With Biosimilars Expertise? - The Web master, Ronald A. Rader, is available.  See his short bio and full resume. Mr. Rader is the author of BIOPHARMA, the only information resource/reference specializing in biopharmaceuticals (see www.biopharma.com), has authored the defining articles concerning biopharmaceuticals and biosimilars/FOBs (e.g., see the "What is...", "(Re)Defining" and related abstracts/links above), and is a world-class expert concerning biopharmaceutical information, products, techologies, and related market, technology and policy assessments.

Sponsors needed!   Without financing and/or collaboration with a view towards the long term, we (Biotech. Info. Inst.) do not foresee near-term commercial viability for our solely developing authoritative biosimilar or other biopharmaceutical information resources. There simply are too few actually involved with too few opportunities for cost-recovery, much less profit. Thus, corporate or other funding or collaboration is needed. We envision developing the best (or only) Web site/database/reference and, perhaps, newsletter providing substantive information about biosimilars (and biobetters and biogenerics). While everyone else concentrates on wimpy consumer and health care professional information, this site concentrates on providing substantive and authoritative information. This could be done for the public good (the preferred outcome), as a commercial investment, or as an advocacy/lobbying effort (an incredibly cost-effective opportunity to educate and influence the industry, regulatory and medical communitities' and the public's views concerning biosimilars/biopharmaceuticals, i.e., promote your vested interests). We welcome discussing all forms of sponsorship, including as tax-deductable contributions or grants to the BIOPHARMA Institute, Inc., a currently dormant corporation slated to receive IRS 501c(3) tax-exempt status. To learn more, contact Ron Rader.